AZASITE SOL 1% 阿奇霉素滴眼液 azithromycin ophthalmic solution
2007年4月底,美国FDA批准英斯皮雷制药(Inspire Pharmaceuticals)公司的1%阿齐霉素滴眼液(商品名:AzaSite)上市,用于治疗细菌性结膜炎。
AzaSite Plus™
AzaSite Plus (ISV-502) is a product candidate in the AzaSite family currently under development for the treatment of conditions such as blepharitis that involve both bacterial infection and inflammation. Blepharitis, which affects tens of millions of people worldwide, causes symptoms such as redness, irritation, and scaly skin at the edges of the eyelids. AzaSite Plus is a fixed-dose combination of an antibiotic (1.0% azithromycin) and an anti-inflammatory steroid (0.1% dexamethasone). AzaSite Plus is formulated with our DuraSite® drug delivery technology.
AZASITE Rx
Generic Name and Formulations:
Azithromycin 1%; oph. soln; contains benzalkonium chloride.
Company:
Akorn, Inc.
Indications for AZASITE:
Susceptible bacterial conjunctivitis.
Adults and Children's Dose:
<1yr: not recommended. ≥1yr: 1 drop in affected eye(s) twice daily (8–12hrs apart) for 2 days then once daily for the next 5 days.
Pharmacological Class:
Macrolide.
Warnings/Precautions:
Remove contact lenses during therapy. Pregnancy (Cat.B). Nursing mothers.